Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Net sales of DARZALEX® in the first quarter of 2026 totaled USD 3,964 millionGenmab receives royalties on worldwide net sales from Johnson & Johnso [Read more]